The document discusses several types of infections that affect the alimentary, hepatic, and genitourinary systems. It provides details on the symptoms, causative agents, transmission routes, prevention, and treatment options for rotavirus and norovirus gastroenteritis, various forms of viral hepatitis (A-E), genital herpes, human papillomavirus, and poliovirus. Vaccines have been developed for rotavirus, hepatitis A, and poliovirus to help prevent the spread of these infectious diseases.
The document discusses several types of infections that affect the alimentary, hepatic, and genitourinary systems. It provides details on the symptoms, causative agents, transmission routes, prevention, and treatment options for rotavirus and norovirus gastroenteritis, various forms of viral hepatitis (A-E), genital herpes, human papillomavirus, and poliovirus. Vaccines have been developed for rotavirus, hepatitis A, and poliovirus to help prevent the spread of these infectious diseases.
The document discusses several types of infections that affect the alimentary, hepatic, and genitourinary systems. It provides details on the symptoms, causative agents, transmission routes, prevention, and treatment options for rotavirus and norovirus gastroenteritis, various forms of viral hepatitis (A-E), genital herpes, human papillomavirus, and poliovirus. Vaccines have been developed for rotavirus, hepatitis A, and poliovirus to help prevent the spread of these infectious diseases.
Gastroenteritis • Symptoms: – Vomiting and slightly fever – Watery diarrhea – Symptoms are gone in about 3-7 days • Pathogenesis The viruses infect the epithelium in the upper part of small intestine, causing decreased production of digestive enzymes Rotavirus and Norwalk virus Gastroenteritis • Epidemiology – Spread by oral-fecal route – Generally occur in winter (Children) • Prevention – Handwashing, disinfectant use limit the spread of viruses – Attenuated vaccine (Rotavirus) approved in 1998, then withdraw the next year (Bowel obstruction) – No vaccine for Norwalk viruses Hepatitis • Viral hepatitis is an infection of the liver hepatocytes by viruses. There are 5 known viruses that infect the liver. • The 5 RNA viruses are: • 1) Hepatitis A virus (HAV). • 2) Hepatitis C virus (HCV), which was previously called NON-A NON-B until it was isolated. • 3) Hepatitis D virus (HDV). • 4) Hepatitis E virus (HEV). • 5) Hepatitis G virus.(HGV) • There is 1 DNA virus called: • 1) Hepatitis B virus (HBV)
ABCDE, A = Anal, E = Enteric (Fecal oral route)
• BCD = Blood (parenteral) • VIRAL HEPATITIS 1. Acute viral hepatitis can be caused by all of these viruses. Symptomatic, patient may develop jaundice Elevation liver-function enzymes aspartate aminotransferase (AST), alanine aminotransferase (ALT), gamma-glutamyl transpeptidase (GGT), and alkaline phosphatase.
2. Chronic viral hepatitis.
The parenterally (blood-to-blood) transmitted HBV, HCV Is more difficult to diagnose because the patient is often asymptomatic with only an enlarged tender liver and mildly elevated liver function enzyme levels. Hepatitis • Hepatitis A (HAV) • Symptoms: • Fatigue, fever, loss of appetite, nausea, dark- colored urine, clay-colored feces and jaundice • Pathogenesis: – Following ingestion, the virus reach the liver – Replication and tissue damage – The virus released into bile – The virus eliminated with feces HAV • Epidemiology: – Spread by fecal-oral route – Fecal contamination of hand, food and water – Children with HAV can eliminate the virus with their feces for several months after symptoms begin HAV • Prevention and treatment –Inactivated vaccine available since 1995 –IgG to HAV as passive immunization of people exposed to virus –No antiviral is available, just supportive HBV • Symptoms: – Similar to HAV, except that HBV tend to be more sever. Cause death in 1% - 10% of hospitalized cases. • Causative agent The important HBV antigens are: – Surface antigen (HBsAg) – Core antigen (HBcAg) – Soluble component of core (HBeAg) HCV • Symptoms – The same of A and B, except is milder – About 65% have no symptoms – Only 25% have jaundice • Pathogenesis: – Spread mainly by blood – Infect the liver (incubation 2 – 6 weeks) – 80% develop chronic infection – Liver wax – After years cirrhosis and liver cancer develop in 10- 20% of patients Genitourinary tract infections (Viral STDs) Genital Herpes Simplex (HSV) • Symptoms: Itching, burning pain, painful urination, tiny blisters • Incubations: Usually 1 week • Causative agent: HSV-2, HSV-1 can also be responsible. Enveloped, dsDNA • Pathogenesis: Lysis of infected epithelial cell, fluid filled blister containing virions. Rupture of these vesicles causes ulceration. Recurrent symptoms supplied by nerve • Epidemiology: Human is the only reservoirs, through sexual intercourse or direct contact • Prevention and treatment: Medication can only prevent recurrence. No cure Papillomavirus (HPV) Genital warts and cervical cancer • Symptoms: Many have no symptoms, skin warts the most common • Incubations: Usually 3 months • Causative agents: Human papillomaviruses, naked dsDNA, different types infect different tissues • Pathogenesis: Virus enter through damaged skin, infect deep layer, establishes latency, cancer-associated viruses • Epidemiology: Asymptomatic individuals can transmit the disease, through sexual contact • Prevention and treatment: Yearly Pap test is advised, warts removal (Freezing or cauterization and laser therapy) does not cure the infection • Malignant lesions treated surgically Papillomavirus (HPV) Skin warts Nervous System Infections Asymmetric poliomyelitis Salk and Sabin vaccine • Salk The dead or inactivated vaccine has the advantage of a long stability period and application safety. The disadvantages of this vaccine form are its high cost, the requirement for three injections . • Sabin The advantages of the live vaccine are its oral application route, low price and high level of efficiency. One disadvantage is presented by the (1 in 1 x 106) cases of paralysis (vaccination-associated paralytic poliomyelitis, VAPP) resulting from a vaccination.